Novel Integration of New prostate radiation therapy schedules with adJuvant Androgen deprivation

In men with intermediate and high-risk prostate cancer, the NINJA trial is looking at comparing two different radiotherapy treatment schedules called stereotactic body radiotherapy (SBRT). The aim is to develop better methods of treatment for prostate cancer using this type of treatment, and further understand what causes some of the side effects of treatments. It is hoped this research will potentially improve the accuracy and quality of radiotherapy treatment in prostate cancer.

Primary Sponsor

Trans Tasman Radiation Oncology Group (TROG)

Collaborating Groups

Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Participating Centres

Accrual Target

472

Current Accrual

Trial Chairperson

Prof Jarad Martin, Calvary Mater Hospital, NSW, Australia
Dr Mark Sidhom, Liverpool Hospital, NSW, Australia

Trial Contact

ninjatrial@calvarymater.org.au

Clinical Trial Registration

Related Post

26 November, 2025

TROG Member Prof Paul Keall’s innovative research recognised in two Premier’s Awards

LATEST NEWS; 26 November 2025 Medical physics researcher and

25 November, 2025

Automated quality assurance tool shows promise in TROG 18.01 NINJA trial

LATEST NEWS: 25 November 2025 Vital quality assurance (QA)